Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;23 Suppl 1(Suppl 1):2-6.
doi: 10.1007/s11606-007-0237-x.

"It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life

Nathan E Goldstein  1 , Davendra Mehta, Ezra Teitelbaum, Elizabeth H Bradley, R Sean Morrison
Affiliations

"It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life

Nathan E Goldstein et al. J Gen Intern Med. 2008 Jan.

Abstract

Objective: To understand potential barriers to physician-initiated discussions about Implantable Cardioverter Defibrillator (ICD) deactivation in patients with advanced illness.

Design: Qualitative one-on-one interviews.

Participants: Four electrophysiologists, 4 cardiologists, and 4 generalists (internists and geriatricians) from 3 states.

Approach: Clinicians were interviewed using open-ended questions to elicit their past experiences with discussing deactivating ICDs and to determine what barriers might impede these discussions. Transcripts of these interviews were analyzed using the qualitative method of constant comparison.

Results: Although many physicians believed that conversations about deactivating ICDs should be included in advance care planning discussions, they acknowledged that they rarely did this. Physicians indicated that there was something intrinsic to the nature of these devices that makes it inherently difficult to think of them in the same context as other management decisions at the end of a patient's life. Other explanations physicians gave as to why they did not engage in conversations included: the small internal nature of these devices and hence absence of a physical reminder to discuss the ICD, the absence of an established relationship with the patient, and their own general concerns relating to withdrawing care.

Conclusion: Whereas some of the barriers to discussing ICD deactivation are common to all forms of advance care planning, ICDs have unique characteristics that make these conversations more difficult. Future educational interventions will need to be designed to teach physicians how to improve communication with patients about the management of ICDs at the end of life.

PubMed Disclaimer

Comment in

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199912163412503', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199912163412503'}, {'type': 'PubMed', 'value': '10601507', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10601507/'}]}
    2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prytowsky EN, Hafley GA. Randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1993;341(25):1882–90. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199612263352601', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199612263352601'}, {'type': 'PubMed', 'value': '8960472', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8960472/'}]}
    2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335(26):1933–40. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa013474', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa013474'}, {'type': 'PubMed', 'value': '11907286', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11907286/'}]}
    2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa043399', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa043399'}, {'type': 'PubMed', 'value': '15659722', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15659722/'}]}
    2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15583224', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15583224/'}]}
    2. Goldstein NE, Lampert R, Bradley EH, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835–38. - PubMed

Publication types